BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35613806)

  • 1. Safety of COVID-19 vaccines in patients with non-communicable diseases: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Shi C; Wu M; Wang X; Yang K
    BMJ Open; 2022 May; 12(5):e057233. PubMed ID: 35613806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials.
    Medeiros KS; Costa APF; Sarmento ACA; Freitas CL; Gonçalves AK
    BMJ Open; 2022 Feb; 12(2):e050278. PubMed ID: 35210336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects of COVID-19 vaccines in paediatric patients: a review systematic and meta-analysis protocol.
    Freitas CL; Sarmento ACA; Serquiz N; Nobre ML; Costa APF; Medeiros KS; Gonçalves AK
    BMJ Open; 2024 Apr; 14(4):e076064. PubMed ID: 38594182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis.
    Li M; Yang X; Jiang L; Yang D
    BMJ Open; 2021 Nov; 11(11):e056106. PubMed ID: 34740936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mesenchymal stem cells for the treatment of patients infected with COVID-19: a systematic review and meta-analysis protocol.
    Chen Y; Zhang Q; Peng W; Liu D; You Y; Liu X; Tang S; Zhang T
    BMJ Open; 2020 Dec; 10(12):e042085. PubMed ID: 33371042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project).
    Korang SK; Juul S; Nielsen EE; Feinberg J; Siddiqui F; Ong G; Klingenberg S; Veroniki AA; Bu F; Thabane L; Thomsen AR; Jakobsen JC; Gluud C
    Syst Rev; 2020 Nov; 9(1):262. PubMed ID: 33218366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of telecardiac rehabilitation with centre-based cardiac rehabilitation and usual care: a protocol for systematic review including a meta-analysis.
    Bashir Z; Shahab A; Imran H
    Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and security of glycyrrhizic acid preparation in the treatment of anti-SARS-CoV-2 drug-induced liver injury: a protocol of systematic review and meta-analysis.
    Tian X; Gan W; Nie Y; Ying R; Tan Y; Chen J; Chen M; Zhang C
    BMJ Open; 2021 Jul; 11(7):e051484. PubMed ID: 34244286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of arsenic trioxide combined with platinum drugs in treatment of cervical cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Pan D; Yang H; Huang J; He Z; Li H; Li D
    Medicine (Baltimore); 2020 Nov; 99(45):e22950. PubMed ID: 33157935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mass testing for control of COVID-19: a systematic review protocol.
    Lopes-Júnior LC; Bomfim E; Silveira DSCD; Pessanha RM; Schuab SIPC; Lima RAG
    BMJ Open; 2020 Aug; 10(8):e040413. PubMed ID: 32847926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of COVID-19 and SARS-CoV-2 on male reproductive function: a systematic review and meta-analysis protocol.
    Li X; Lu H; Li F; Zhang Q; Wang T; Qiang L; Yang Q
    BMJ Open; 2022 Jan; 12(1):e053051. PubMed ID: 34987042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship between physical activity and mortality in people with non-communicable diseases: a study protocol for the systematic review and meta-analysis of cohort studies.
    Geidl W; Schlesinger S; Mino E; Miranda L; Ryan A; Bartsch K; Janz L; Pfeifer K
    BMJ Open; 2019 Sep; 9(9):e028653. PubMed ID: 31511283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
    Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
    BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective components of exercise and physical activity-related behaviour-change interventions for chronic non-communicable diseases in Africa: protocol for a systematic mixed studies review with meta-analysis.
    Igwesi-Chidobe CN; Godfrey EL; Kengne AP
    BMJ Open; 2015 Aug; 5(8):e008036. PubMed ID: 26270945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events associated with human papillomavirus vaccines: a protocol for systematic review with network meta-analysis incorporating all randomised controlled trials comparing with placebo, adjuvants and other vaccines.
    Takeuchi J; Noma H; Sakanishi Y; Kawamura T
    BMJ Open; 2019 Aug; 9(8):e026924. PubMed ID: 31439596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 on sexual behaviors of young women and men: A protocol for systematic review and meta analysis.
    Zhang Q; Lu H; Li F; Li X; Wang T; Yang Q; Mi L
    Medicine (Baltimore); 2021 Feb; 100(8):e24415. PubMed ID: 33663053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.